Awarded stature CIS has recently been recognized as a top business and as a 2025 Best Research Center in Gurnee, IL, signaling credibility and potential leverage when approaching larger pharma players seeking reputable CRO/SMO partnerships.

Clinical depth With experience conducting Phase I-IV trials across multiple sites in Illinois and Wisconsin and a network of board-certified physicians, CIS can position itself as a flexible, high-touch partner for sponsor programs needing personalized trial management and rapid site activation.

Multi-site value The robust multi-site network and combination of CRO, SMO, and hands-on research management services present a compelling value proposition for sponsors seeking streamlined trial execution, patient access, and efficient pipeline progression.

Growth-ready model Revenue in the low to mid single-digit millions alongside a scalable service model indicates room to pursue mid-market and emerging biotech clients, offering expansion into additional therapeutic areas and geography with existing CIS/MD physician network.

Tech-enabled care Adoption of modern tech stack elements (iCIMS, Google Maps, GTM, and other web technologies) suggests operational readiness for streamlined trial workflows, patient recruitment tooling, and data capture improvements that can be showcased to sponsors seeking efficiency gains.